These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 9722142

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
    Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Costa D, Perry RH, Perry EK.
    Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey.
    Farfel GM, Kleven MS, Woolverton WL, Seiden LS, Perry BD.
    Brain Res; 1992 Apr 24; 578(1-2):235-43. PubMed ID: 1380862
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
    Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Perry RH, Perry EK.
    Neuroscience; 2000 Apr 24; 98(1):79-87. PubMed ID: 10858614
    [Abstract] [Full Text] [Related]

  • 8. Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage.
    McCallum SE, Parameswaran N, Bordia T, McIntosh JM, Grady SR, Quik M.
    Mol Pharmacol; 2005 Sep 24; 68(3):737-46. PubMed ID: 15933214
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex.
    Drew AE, Derbez AE, Werling LL.
    Synapse; 2000 Oct 24; 38(1):10-6. PubMed ID: 10941136
    [Abstract] [Full Text] [Related]

  • 13. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.
    Madras BK, Gracz LM, Fahey MA, Elmaleh D, Meltzer PC, Liang AY, Stopa EG, Babich J, Fischman AJ.
    Synapse; 1998 Jun 24; 29(2):116-27. PubMed ID: 9593102
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment.
    Mattila PM, Röyttä M, Lönnberg P, Marjamäki P, Helenius H, Rinne JO.
    Acta Neuropathol; 2001 Aug 24; 102(2):160-6. PubMed ID: 11563631
    [Abstract] [Full Text] [Related]

  • 17. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
    Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, Riederer P, Jellinger K, Tourtellotte WW.
    Neuropsychopharmacology; 1987 Dec 24; 1(1):5-15. PubMed ID: 2908095
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
    Dickinson SD, Sabeti J, Larson GA, Giardina K, Rubinstein M, Kelly MA, Grandy DK, Low MJ, Gerhardt GA, Zahniser NR.
    J Neurochem; 1999 Jan 24; 72(1):148-56. PubMed ID: 9886065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.